foxo4-dri latest research 2025 or 2026 FOX04-DRI FOXO4-DRI UK | Senolytic Peptide

You can Register, Sponsor or Advertise online or by mail

Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials

[DOI] [PubMed] [Google Scholar] 119.Bocca C., Novo E., Miglietta A., Parola M

Our team is ready to assist you promptly and professionally

4-6 weeks 1 vial 4 weeks: 28 doses needed

Results are personalised